# Australasian Nanoparticle-mediated Magnetically Enhanced Diffusion for Ischemic Stroke

> **NCT06495671** · NA · NOT_YET_RECRUITING · sponsor: **University of Melbourne** · enrollment: 30 (estimated)

## Conditions studied

- Ischemic Stroke
- Stroke

## Interventions

- **DEVICE:** Magnetically enhanced diffusion

## Key facts

- **NCT ID:** NCT06495671
- **Lead sponsor:** University of Melbourne
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-07-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06495671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06495671, "Australasian Nanoparticle-mediated Magnetically Enhanced Diffusion for Ischemic Stroke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06495671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*